Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers

NCT02571738 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
108
Enrollment
INDUSTRY
Sponsor class

Stopped Company's desire to allocate more research and development resources to other clinical programs. Decision not driven by any safety concerns.

Conditions

Interventions

Sponsor

Osiris Therapeutics